Introduction Spinal cord injury in adult mammals results in little axonal regeneration, although the mechanism of regeneration failure still remains elusive. However, several animal studies have succeeded in inducing functional recovery after experimental spinal cord injury. In vivo gene delivery of neurotrophic factors to motor neurons using viral vectors prevented axotomy-induced neuronal degeneration (1) , and grafting of genetically-modified fibroblats which express BDNF (2) or to the transected spinal cord lesions promoted axonal regeneration and induced functional recovery of limbs. The specific receptors of these neurotrophic factors transduce their signals via signaling cascades : Ras-Raf-MEK-MAP kinase pathway and phosphatidylinositol 3-kinase-Akt pathway. Recent research has revealed that activation of the extracellular-signal-regulated kinases (ERKs) plays an important role in the neurite outgrowth. In the present study, we constructed a replication-defective adenovirus vector carrying mutated form of MEK1, which constitutively activate ERK pathway, and investigated its effect on thoracic spinal cord injury model in young adult rats as well as neurite outgrowth in vitro.
Introduction Spinal cord injury in adult mammals results in little axonal regeneration, although the mechanism of regeneration failure still remains elusive. However, several animal studies have succeeded in inducing functional recovery after experimental spinal cord injury. In vivo gene delivery of neurotrophic factors to motor neurons using viral vectors prevented axotomy-induced neuronal degeneration (1) , and grafting of genetically-modified fibroblats which express BDNF (2) or NT-3 (3) to the transected spinal cord lesions promoted axonal regeneration and induced functional recovery of limbs. The specific receptors of these neurotrophic factors transduce their signals via signaling cascades : Ras-Raf-MEK-MAP kinase pathway and phosphatidylinositol 3-kinase-Akt pathway. Recent research has revealed that activation of the extracellular-signal-regulated kinases (ERKs) plays an important role in the neurite outgrowth. In the present study, we constructed a replication-defective adenovirus vector carrying mutated form of MEK1, which constitutively activate ERK pathway, and investigated its effect on thoracic spinal cord injury model in young adult rats as well as neurite outgrowth in vitro.
Materials and Methods
We generated constitutively active MEK1 mutant by substitution of serine 218 and serine 222 by glutamic acid. The replication-deficient recombinant adenovirus vectors, deleted in E1 and E3 region, carrying rat constitutively active MEK1 (CA-MEK virus) or β-galactosidase gene (LacZ virus) under the control of the CAG [cytomegalovirus IE enhancer + chicken β-actin promoter + rabbit β-globin poly (A) signal] promoter were constructed by homologous recombination between the expression cosmid cassette and the parental virus genome in human embryonic kidney 293 cells utilizing established methods. Viral titers of CA-MEK virus and LacZ virus were adjusted to 8.0 x 10 9 PFU (plaqueforming units) /ml. The biological activities of CA-MEK virus in vitro were studied in rat pheocromocytoma cell line PC12 cells. The expression of MEK and the activation of ERKs were studied by western blotting with anti-MEK antibody and anti-phospho-ERK antibody, respectively. Neurite growth after virus infection was studied compared to that after stimulation with NGF. Inbred male Sprague-Dawley (SD) rats, 5 to 6 weeks old weighing 130 to 180 g, were used in vivo study. Spinal cord was transected completely at T10. Adenovirus vector (8.0 x 10 9 PFU/ml) was injected into the both stumps (5 µl into each stump parenchyma) and in the vicinity of the transection site (40 µl) through a glass micropipette to which a Hamilton syringe was attached. Experimental animals were divided into 3 groups: treatment with CA-MEK virus (CA-MEK rat), with LacZ virus (LacZ rat) and with no virus (Tx rat). Transgene expression in vivo was investigated by X-gal histochemistry and immunohistochemistry with anti-phospho-ERK antibody. Hind limb function was evaluated every week using Basso, Bresnahan, and Beattie (BBB) open field locomotion rating score. Recovery of experimental rats was followed up to 6 weeks after the operation and then analyzed for re-transection, tracing study, or electrophysiological study.
Results CA-MEK virus infection induced sustained activation of ERKs and stimulated neurite outgrowth in the absence of neurotrophic factors. In rat spinal cord transection model, injection of CA-MEK virus into the completely transected spinal cord efficiently activated ERKs in the supraspinal neurons such as red nucleus and locus coerulerus and induced axonal regeneration across the transection site, which was confirmed by anterograde labeling with wheat-germ-agglutinin conjugated peroxidase (WGA-HRP). Spinal cord evoked potentials (SCEP) showed that these regenerated axons were electroconductive. Most importantly, CA-MEK virustreated rats showed significant recovery of hind limb function 2 weeks after operation compared to the control rats treated with no virus or LacZ virus. Re-transection caused complete loss of the locomotion activities immediately after re-transection, eith no obvious functional recovery at least within 4 weeks.
Discussion
We showed here that we could induce transgene expression in neurons not only in vitro but also in vivo using adenovirus vector. The mechanism of the functional recovery of CA-MEK-treated rats could be explained by the enhanced ability of neurite outgrowth of the supraspinal neurons induced by the CA-MEK virus-mediated sustained ERK activation, although further investigation will be required to elucidate the mechanism of the accelerated axonal regeneration induced by CA-MEK virus. Our results suggest that adenovirus-mediated CA-MEK gene transduction offers a novel strategy for the gene therapy of spinal cord injury. 
